author-photo

Mathias Lutz

University of Münster

7

Papers

66

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma.

2021 Nature Communications
Show All
- Source
- Cite
- Save
Citations (8)
New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease.

2016 British Journal of Clinical Pharmacology
- Mathias Lutz
- Stephan Mielke
Show All
- Source
- Cite
- Save
Citations (22)
Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapy.

2015 Blood
Show All
- Source
- Cite
- Save
Citations (11)
Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: a dual center retrospective analysis.

2014 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (17)
Improvement of quality of life in patients with steroid‐refractory chronic graft‐versus‐host disease treated with the mTOR inhibitor everolimus

2014 Clinical Transplantation
Show All
- Source
- Cite
- Save
Citations (6)
Salvage Therapy with Everolimus Reduces the Severity of Treatment-Refractory Chronic Graft-Versus-Host Disease without Impairing Disease Control: A Dual Center Experience

2012 Blood
Show All
- Source
- Cite
- Save
Citations (1)